Correlative CD4 and CD8 T-cell immunodominance in humans and mice: Implications for preclinical testing.


Journal

Cellular & molecular immunology
ISSN: 2042-0226
Titre abrégé: Cell Mol Immunol
Pays: China
ID NLM: 101242872

Informations de publication

Date de publication:
11 2023
Historique:
received: 06 07 2023
accepted: 28 08 2023
medline: 1 11 2023
pubmed: 20 9 2023
entrez: 19 9 2023
Statut: ppublish

Résumé

Antigen-specific T-cell recognition is restricted by Major Histocompatibility Complex (MHC) molecules, and differences between CD4 and CD8 immunogenicity in humans and animal species used in preclinical vaccine testing are yet to be fully understood. In this study, we addressed this matter by analyzing experimentally identified epitopes based on published data curated in the Immune Epitopes DataBase (IEDB) database. We first analyzed SARS-CoV-2 spike (S) and nucleoprotein (N), which are two common targets of the immune response and well studied in both human and mouse systems. We observed a weak but statistically significant correlation between human and H-2

Identifiants

pubmed: 37726420
doi: 10.1038/s41423-023-01083-0
pii: 10.1038/s41423-023-01083-0
pmc: PMC10616275
doi:

Substances chimiques

Epitopes, T-Lymphocyte 0

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1328-1338

Subventions

Organisme : NIAID NIH HHS
ID : 75N93019C00001
Pays : United States
Organisme : NIAID NIH HHS
ID : 75N93019C00065
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2023. The Author(s), under exclusive licence to CSI and USTC.

Références

Cell. 2020 Nov 12;183(4):996-1012.e19
pubmed: 33010815
Nat Immunol. 2022 Feb;23(2):186-193
pubmed: 35105982
Immunoinformatics (Amst). 2022 Dec;8:100020
pubmed: 36337685
Immunity. 2022 May 10;55(5):738-748
pubmed: 35545026
Nature. 2022 Jan;601(7891):110-117
pubmed: 34758478
Proc Natl Acad Sci U S A. 1989 Jun;86(12):4649-53
pubmed: 2471972
Cell. 2021 Feb 18;184(4):861-880
pubmed: 33497610
Hum Immunol. 2000 Mar;61(3):334-40
pubmed: 10689125
J Immunol. 1991 Oct 15;147(8):2663-9
pubmed: 1717570
Sci Rep. 2016 Sep 16;6:33612
pubmed: 27634283
J Immunol. 2007 Jun 15;178(12):7890-901
pubmed: 17548627
Immunogenetics. 2011 Jun;63(6):325-35
pubmed: 21305276
Emerg Infect Dis. 2006 Jan;12(1):48-54
pubmed: 16494717
Immunol Res. 1990;9(2):115-22
pubmed: 2189934
Nat Med. 2012 Jan 29;18(2):274-80
pubmed: 22286307
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4587-92
pubmed: 11287644
Sci Immunol. 2020 Jul 17;5(49):
pubmed: 32680954
Front Immunol. 2019 Sep 04;10:2125
pubmed: 31552052
Int J Mol Sci. 2020 Dec 05;21(23):
pubmed: 33291453
J Immunol. 2008 Jun 1;180(11):7193-202
pubmed: 18490718
Bioinformatics. 2004 Aug 4;20 Suppl 1:i297-302
pubmed: 15262812
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Immunity. 2006 Oct;25(4):533-43
pubmed: 17046682
Annu Rev Immunol. 2020 Apr 26;38:123-145
pubmed: 32045313
Med Microbiol Immunol. 2019 Aug;208(3-4):415-429
pubmed: 30923898
Nature. 1987 Oct 1-7;329(6138):447-9
pubmed: 2821399
Immunogenetics. 1999 Nov;50(3-4):201-12
pubmed: 10602880
Cell Rep. 2021 Feb 9;34(6):108728
pubmed: 33516277
Hum Immunol. 2001 Nov;62(11):1200-16
pubmed: 11704282
Immunity. 2022 Oct 11;55(10):1764-1778
pubmed: 36049482
Front Immunol. 2022 May 06;13:812393
pubmed: 35603215
Cold Spring Harb Perspect Biol. 2018 Apr 2;10(4):
pubmed: 28348037
Annu Rev Immunol. 1991;9:297-322
pubmed: 1910680
J Am Soc Nephrol. 2013 Feb;24(3):419-31
pubmed: 23411782
Immunogenetics. 2013 May;65(5):357-70
pubmed: 23392739
Immunol Rev. 2018 Jul;284(1):91-105
pubmed: 29944766
Front Immunol. 2018 Jun 14;9:1369
pubmed: 29963059
Annu Rev Immunol. 2010;28:275-94
pubmed: 20307209
Bioinformatics. 2018 Nov 15;34(22):3931-3933
pubmed: 29878047
Science. 1996 Apr 5;272(5258):67-74
pubmed: 8600539
Nat Commun. 2022 Jan 10;13(1):80
pubmed: 35013199
Adv Immunol. 1975;20:125-95
pubmed: 47219
Annu Rev Immunol. 1999;17:51-88
pubmed: 10358753
J Immunol. 2007 Jun 1;178(11):6814-20
pubmed: 17513729
Cell. 2022 Mar 3;185(5):847-859.e11
pubmed: 35139340
J Immunol. 2010 Jul 15;185(2):943-55
pubmed: 20554959
Virology. 2013 Dec;447(1-2):181-6
pubmed: 24210113
PLoS Pathog. 2007 Oct 12;3(10):1511-29
pubmed: 17937498
Immunogenetics. 2012 Jun;64(6):421-34
pubmed: 22322672
Biochem Biophys Res Commun. 2021 Jan 29;538:211-217
pubmed: 33190827
Immunome Res. 2009 Jun 17;5:3
pubmed: 19534819
Immunome Res. 2010 May 17;6:4
pubmed: 20478058
J Infect Dis. 2011 Apr 15;203(8):1043-53
pubmed: 21450994
Immunity. 2013 Nov 14;39(5):939-48
pubmed: 24238342
Viral Immunol. 2014 Jun;27(5):225-34
pubmed: 24821387
Immunol Rev. 1999 Jun;169:67-79
pubmed: 10450509
Nature. 2022 Mar;603(7901):488-492
pubmed: 35102311
J Exp Med. 1996 Jun 1;183(6):2635-44
pubmed: 8676084
Nucleic Acids Res. 2019 Jan 8;47(D1):D339-D343
pubmed: 30357391
Annu Rev Immunol. 2023 Apr 26;41:343-373
pubmed: 36750314
Science. 1991 Sep 20;253(5026):1417-20
pubmed: 1910207
Nucleic Acids Res. 2020 Jan 8;48(D1):D783-D788
pubmed: 31722398
Nat Rev Genet. 2004 Dec;5(12):889-99
pubmed: 15573121
Science. 1972 Jan 21;175(4019):273-9
pubmed: 4109878
Nat Commun. 2016 Nov 21;7:13404
pubmed: 27869121
Nat Commun. 2022 Sep 21;13(1):5422
pubmed: 36130936
Infect Genet Evol. 2017 Dec;56:75-91
pubmed: 29107145
J Exp Med. 1995 Mar 1;181(3):867-75
pubmed: 7532684
Vaccines (Basel). 2021 Sep 26;9(10):
pubmed: 34696190
Pathogens. 2019 Nov 05;8(4):
pubmed: 31694141
Immunol Rev. 2006 Jun;211:320-37
pubmed: 16824139
JCI Insight. 2016 Jul 7;1(10):
pubmed: 27468427
Nat Rev Immunol. 2022 Dec;22(12):751-764
pubmed: 35418563
Transfus Med Hemother. 2010;37(6):351-364
pubmed: 21483466
J Immunol. 1994 Dec 15;153(12):5586-92
pubmed: 7527444
Int J Cancer. 2002 Aug 10;100(5):565-70
pubmed: 12124806
BMC Immunol. 2008 Jan 22;9:1
pubmed: 18211710
Int J Mol Sci. 2022 Jun 28;23(13):
pubmed: 35806161
J Immunol. 1998 Apr 1;160(7):3363-73
pubmed: 9531296
Cell Host Microbe. 2021 Jul 14;29(7):1076-1092
pubmed: 34237248
Semin Immunol. 2020 Aug;50:101418
pubmed: 33131981
J Immunol. 2005 Dec 1;175(11):7550-9
pubmed: 16301664
Eur J Immunol. 1996 Jan;26(1):97-101
pubmed: 8566090

Auteurs

Tertuliano Alves Pereira Neto (TAP)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, 92037, USA.

John Sidney (J)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, 92037, USA.

Alba Grifoni (A)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, 92037, USA. agrifoni@lji.org.

Alessandro Sette (A)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology (LJI), La Jolla, CA, 92037, USA.
Department of Medicine, Division of Infectious Diseases and Global Public Health, University of California, San Diego, La Jolla, CA, 92037, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH